OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Urinary Tract Obstruction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,328 reports · 61 co-occurring drugs

As of the last recalculation, Urinary Tract Obstruction appears in 2,328 FAERS reports alongside 61 co-occurring drug terms. The strongest observed disproportionality signal is BICALUTAMIDE (PRR 17.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Bicalutamide3017.817.9
Abiraterone2013.213.3
Abiraterone Acetate4910.910.9
Dextrose1510.210.3
Dextrose Monohydrate1510.110.1
Tranexamic Acid1010.110.1
Dutasteride99.99.9
Docusate Sodium 100Mg269.89.8
Busulfan179.79.7
Leuprolide Acetate799.49.4
Fesoterodine Fumarate119.19.1
Goserelin138.78.7
Finasteride578.68.6
Azacitidine For178.48.4
Tamsulosin Hydrochloride198.48.4
Sotalol Hydrochloride158.18.1
Durvalumab188.08.0
Enzalutamide517.97.9
Niacin107.77.7
Irinotecan Hydrochloride117.77.7
Mesna Injection77.67.6
Mesna77.57.5
Levodopa107.47.4
Remdesivir117.47.4
Polatuzumab Vedotin87.47.4
Ropinirole127.07.0
Gemcitabine286.46.4
Azacitidine216.46.4
Gemcitabine Hydrochloride376.36.3
Eplerenone96.36.3
Granisetron Hydrochloride76.06.0
Paclitaxel605.55.5
Metoclopramide335.45.4
Granisetron65.15.1
Atezolizumab225.15.1
Bevacizumab685.05.0
Obinutuzumab94.94.9
Regorafenib64.64.6
Ifosfamide114.64.6
Relugolix124.64.6
Cisplatin394.54.5
Paclitaxel (Aibumin-Bound)414.54.5
Vibegron44.54.5
Dapagliflozin154.34.3
Pemetrexed104.24.2
Ibrutinib364.04.0
Vismodegib44.04.0
Carboplatin513.63.6
Ethyl Alcohol113.63.6
Encorafenib43.63.6
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide43.63.6
Pemetrexed Disodium153.53.5
Trifluridine And Tipiracil43.33.3
Ipilimumab153.13.1
Pembrolizumab363.13.1
Lenvatinib113.03.0
Nivolumab312.92.9
Venetoclax192.82.8
Axicabtagene Ciloleucel32.72.7
Lutetium Lu 177 Vipivotide Tetraxetan42.72.7
Pegfilgrastim272.52.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.